[Cost-effectiveness analysis of screening strategies for cervical cancer in Tunisia]
AbstractWe aimed to identify the most appropriate screening strategy for cervical cancer [periodicity of 3, 5 or 10 years] for Tunisia, taking into consideration the incidence of the disease, costs of screening and economic implications. We simulated follow-up of a fictitious cohort of 1 million women 35-39 years over 30 years. Computation of yearly medical care costs was based on data from medical files of patients diagnosed with cervical cancer in 2004 at the National Institute of Cancer, Tunis. For a 60% coverage level of screening, cervical cancer reduction would be 49.2% for a 3-year periodicity. The reduction would be 40.3% and 33.1% for 5 and 10 years periodicity respectively. Considering cost-effectiveness, 10-year screening gave the lowest annual cost to avoid 1 cervical cancer case
Lazaar, H. Ben Gobrane, Aounallah Skhiri, H., Oueslati, F., Frikha, H., Achour, N. et al. (2010). [Cost-effectiveness analysis of screening strategies for cervical cancer in Tunisia]. http://www.who.int/iris/handle/10665/117925
EMHJ - Eastern Mediterranean Health Journal, 16 (6), 602-608, 2010
MetadataShow full item record
Showing items related by title and MeSH subject.
Bennis, S.; Meniar, S.; Amarti, A.; Bijou, A. (2007)A retrospective study was conducted between 2000 and 2003 on 1620 women [mean age 39.6 years] in northern Morocco to determine the incidence of cervical cancer and assess the value of cervical smear in the diagnosis. Patients were interviewed using a questionnaire before carrying out a gynaecological examination and taking a cervical smear sample. Of the total sample, 23.1% had an abnormal cervical smear, of whom 5.6% showed intraepithelial lesions, both low and high grade. The women presenting with cervicitis represented the highest percentage ...
Colposcopy, cervical cytology and human papillomavirus detection as screening tools for cervical cancer Al Alwan, N.A. (2001)A cohort of 77 women referred for routine screening or investigation of Pap test abnormality underwent colposcopic examination. Pap-stained liquid-based preparations were diagnosed and categorized according to the Bethesda system. Residual material on the sampling device was used to detect high-risk oncogenic human papillomavirus DNA. Although the colposcopic failure rate was higher than that of cytology, no lesion was missed when both methods were used together. High-risk types were recorded in 24% of patients with atypical squamous cells of ...